Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1, -2, and -3 and co-receptors neuropilin-1 and -2 does not predict bevacizumab response in human astrocytomas. [electronic resource]
Producer: 20161020Description: 173-83 p. digitalISSN:- 1523-5866
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- therapeutic use
- Astrocytoma -- drug therapy
- Bevacizumab -- therapeutic use
- Biomarkers, Tumor -- metabolism
- Brain Neoplasms -- drug therapy
- Child
- Child, Preschool
- Female
- Follow-Up Studies
- Humans
- Immunoenzyme Techniques
- Infant
- Infant, Newborn
- Male
- Middle Aged
- Neoplasm Grading
- Neoplasm Staging
- Neuropilin-1 -- metabolism
- Neuropilin-2 -- metabolism
- Prognosis
- Receptors, Vascular Endothelial Growth Factor -- metabolism
- Survival Rate
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Vascular Endothelial Growth Factor Receptor-1 -- metabolism
- Vascular Endothelial Growth Factor Receptor-2 -- metabolism
- Vascular Endothelial Growth Factor Receptor-3 -- metabolism
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.